Patents Assigned to North Carolina Central University
  • Publication number: 20120322797
    Abstract: Compounds, compositions and methods are provided that comprise selective ?-glucuronidase inhibitors for both aerobic and anaerobic bacteria, especially enteric bacteria normally associated with the gastrointestinal tract. The compounds, compositions and methods can be for inhibiting bacterial ?-glucuronidases and for improving efficacy of camptothecin-derived antineoplastic agents or glucuronidase-substrate agents or compounds by attenuating the side effects caused by reactivation by bacterial ?-glucuronidases of glucuronidated metabolites of camptothecin-derived antineoplastic agents or glucuronidase-substrate agents or compounds.
    Type: Application
    Filed: December 9, 2010
    Publication date: December 20, 2012
    Applicants: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL, NORTH CAROLINA CENTRAL UNIVERSITY, ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
    Inventors: Matthew R. Redinbo, Sridhar Mani, Alfred Williams, John Scott, Li-An Yeh, Bret David Wallace, Kimberly Terry Lane
  • Patent number: 8060943
    Abstract: The proposed device is based on a carbon nanotube oscillator consisting of a finite length outer stationary nanotube and a finite length inner oscillating nanotube. Its main function is to measure changes in the characteristics of the motion of the carbon nanotube oscillating near a sample surface, and profile the roughness of this surface. The device operates in a non-contact mode, thus it can be virtually non-wear and non-fatigued system. It is an alternative to the existing atomic force microscope (AFM) tips used to scan surfaces to determine their roughness.
    Type: Grant
    Filed: August 26, 2009
    Date of Patent: November 15, 2011
    Assignees: University of South Florida, North Carolina Central University
    Inventors: Adrian Popescu, Lilia M. Woods, Igor V. Bondarev
  • Patent number: 5034528
    Abstract: The invention provides pharmaceutical compositions comprising hypolipidemically active derivatives of 1,2,4-triazolidine-3,5-diones, 1,3,5-triazabicyclo[3.1.0]hexane-2,4-diones, and 1,3,5-triazine-2,4(1H,3H)-diones in a pharmaceutically acceptable carrier for treating hyperlipidemia in mammals, particularly humans.
    Type: Grant
    Filed: July 27, 1988
    Date of Patent: July 23, 1991
    Assignees: North Carolina Central University, The University of North Carolina at Chapel Hill
    Inventors: Robert A. Izydore, Iris H. Hall
  • Patent number: 4494547
    Abstract: Isoindoledione compounds of the formula: ##STR1## wherein: R.sub.1 and R.sub.3 each separately is phenyl, substituted phenyl, alkyl of 1 to 4 carbons, --CHO, --CH.sub.2 OR.sub.6, --CO.sub.2 R.sub.6, --COR.sub.6, hydrogen, or together with R.sub.2 is a divalent alkyl or alkenyl group of 3 to 5 carbons which form a cyclic ring;R.sub.2 is phenyl, substituted phenyl, --CH.sub.2 OR.sub.6, --CH.sub.2 CH.sub.2 OR.sub.6, alkyl of 1 to 4 carbons or with either R.sub.1 or R.sub.3 is a divalent alkyl or alkenyl group of 3 to 5 carbons which form a cyclic ring;R.sub.4 and R.sub.5 which may be the same or different each separately is hydrogen, alkyl of 1 to 4 carbons, --OR.sub.6, --CO.sub.2 R.sub.6, --COR.sub.6, --CHO, --CH.sub.2 OR.sub.6 or together R.sub.4 and R.sub.5 is a butadiene radical which forms a benzene ring;R.sub.6 is hydrogen or alkyl of 1 to 4 carbons; provided that R.sub.1 and R.sub.3 are not both phenyl and that when R.sub.4 and R.sub.5 are both hydrogen, R.sub.1, R.sub.2 and R.sub.3 are not all methyl.
    Type: Grant
    Filed: March 30, 1981
    Date of Patent: January 22, 1985
    Assignee: North Carolina Central University
    Inventor: John A. Myers